We have purified, cloned and characterized kallistatin,
a tissue kallikrein-binding protein (KBP) in humans
and rodents. Kallistatin is a unique serine proteinase
inhibitor (serpin) with Phe-Phe residues at the P2 and P1 positions. Structural and functional analysis of kallistatin by site-directed mutagenesis and protein engineering indicate that wild-type kallistatin is selective for tissue kallikrein. Kallistatin is expressed and localized in endothelial and smooth muscle cells of blood vessels and has multiple roles in vascular function independent of the tissue kallikrein-kinin system. First, kallistatin induces vasorelaxation of isolated aortic rings and reduces renal perfusion pressure in isolated rat kidneys. Transgenic mice overexpressing rat kallistatin are hypotensive, and adenovirus-mediated gene delivery
of human kallistatin attenuates blood pressure rise in
spontaneously hypertensive rats. Second, kallistatin
stimulates the proliferation and migration of vascular
smooth muscle cells in vitro and neointima formation
in balloon-injured rat arteries. Third, kallistatin inhibits
the proliferation, migration and adhesion of endothelial
cells
Print ISSN: 1431-6730
Volume: 382, 02/2001
Pages: 15 - 21